Enanta Pharmaceuticals Inc
Veridion Score
BETAMEDIUM CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ENTA moving today?
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ENTA overview
Related filings and maps
Congress activity in ENTA
No receipt-qualified Congressional disclosure is present for ENTA in the cached public ledger.
ENTA contract awards, year to date.
Public federal awards linked to this ticker.
ENTA lobbying filings, year to date.
Registered lobbying filings matched to Enanta Pharmaceuticals Inc.